{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["dysmenorrhea", "gynecological disorders", "herbal products", "medicinal plants", "menopause", "premenstrual syndrome"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "34946512", "DateCompleted": {"Year": "2022", "Month": "02", "Day": "14"}, "DateRevised": {"Year": "2024", "Month": "04", "Day": "07"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "12", "Day": "08"}], "Language": ["eng"], "ELocationID": ["7421", "10.3390/molecules26247421"], "Journal": {"ISSN": "1420-3049", "JournalIssue": {"Volume": "26", "Issue": "24", "PubDate": {"Year": "2021", "Month": "Dec", "Day": "08"}}, "Title": "Molecules (Basel, Switzerland)", "ISOAbbreviation": "Molecules"}, "ArticleTitle": "Herbal Products Used in Menopause and for Gynecological Disorders.", "Abstract": {"AbstractText": ["Herbal products are often used as an alternative to pharmacological therapy. Menopausal symptoms and gynecological disorders (such as premenstrual syndrome and dysmenorrhea) are the indications where pharmacological therapy may have serious adverse events, hence many women prefer to use herbal products to help with these symptoms. Here, we reviewed plants and derived products, which are commonly used for the abovementioned indications, focusing on clinical data, safely profile and whether or not their use is justified. We noted that limited data are available on the use of some plants for alleviating the symptoms of menopause and gynecological disorders. While black cohosh (<i>Cimicifuga racemose</i>) and red clover (<i>Trifolium pretense</i>) were consistently shown to help reduce menopausal symptoms in clinical studies, currently available data do not fully support the use of fenugreek (<i>Trigonella foenum-graecum</i>), hops (<i>Humulus lupulus</i>), valerian (<i>Valeriana officinalis</i>), and soybean (<i>Glycine max</i> and <i>Glycine soja</i>) for this indication. For premenstrual syndrome and premenstrual dysphoric disorder, chaste tree (<i>Vitex agnus-castus</i>) shows effectiveness, but more clinical studies are needed to confirm such effect upon the use of evening primrose (<i>Oenothera biennis</i>)."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "University of Ljubljana, Faculty of Pharmacy, A\u0161ker\u010deva Cesta 7, 1000 Ljubljana, Slovenia."}], "LastName": "Kenda", "ForeName": "Ma\u0161a", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "University of Ljubljana, Faculty of Pharmacy, A\u0161ker\u010deva Cesta 7, 1000 Ljubljana, Slovenia."}], "LastName": "Glava\u010d", "ForeName": "Nina Ko\u010devar", "Initials": "NK"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Comenius University in Bratislava, Faculty of Pharmacy, 83232 Bratislava, Slovakia."}], "LastName": "Nagy", "ForeName": "Milan", "Initials": "M"}, {"Identifier": ["0000-0002-0560-3762"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "University of Ljubljana, Faculty of Pharmacy, A\u0161ker\u010deva Cesta 7, 1000 Ljubljana, Slovenia."}], "LastName": "Sollner Dolenc", "ForeName": "Marija", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "On Behalf Of The Oemonom"}], "GrantList": [{"GrantID": "Project No. 2020-1-CZ01-KA203-078218", "Agency": "the Erasmus+ Programme of the European Union", "Country": ""}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Molecules", "NlmUniqueID": "100964009", "ISSNLinking": "1420-3049"}, "MeshHeadingList": [{"QualifierName": ["drug therapy"], "DescriptorName": "Dysmenorrhea"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["drug effects"], "DescriptorName": "Menopause"}, {"QualifierName": [], "DescriptorName": "Phytotherapy"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Premenstrual Syndrome"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Nedrow A., Miller J., Walker M., Ngyren P., Hoyt Huffman L., Nelson H.D. Complementary and alternative therapies for the management of menopause-related symptoms: A systematic evidence review. Arch. Intern. Med. 2006;166:1453\u20131465. doi: 10.1001/archinte.166.14.1453.", "ArticleIdList": ["10.1001/archinte.166.14.1453", "16864755"]}, {"Citation": "Marjoribanks J., Farquhar C., Roberts H., Lethaby A., Lee J. Long-term hormone therapy for perimenopausal and postmenopausal women. Cochrane Database Syst. Rev. 2017;7:CD004143. doi: 10.1002/14651858.CD004143.pub5.", "ArticleIdList": ["10.1002/14651858.CD004143.pub5", "PMC6465148", "28093732"]}, {"Citation": "Yonkers K.A., O\u2019Brien P.S., Eriksson E. Premenstrual syndrome. Lancet. 2008;371:1200\u20131210. doi: 10.1016/S0140-6736(08)60527-9.", "ArticleIdList": ["10.1016/S0140-6736(08)60527-9", "PMC3118460", "18395582"]}, {"Citation": "Bernardi M., Lazzeri L., Perelli F., Reis F.M., Petraglia F. Dysmenorrhea and related disorders. F1000Research. 2017;6:1645. doi: 10.12688/f1000research.11682.1.", "ArticleIdList": ["10.12688/f1000research.11682.1", "PMC5585876", "28944048"]}, {"Citation": "Dawood M.Y. Dysmenorrhea. Clin. Obstet. Gynecol. 1990;33:168\u2013178. doi: 10.1097/00003081-199003000-00023.", "ArticleIdList": ["10.1097/00003081-199003000-00023", "2178834"]}, {"Citation": "Greendale G.A., Lee N.P., Arriola E.R. The menopause. Lancet. 1999;353:571\u2013580. doi: 10.1016/S0140-6736(98)05352-5.", "ArticleIdList": ["10.1016/S0140-6736(98)05352-5", "10028999"]}, {"Citation": "Kupperman H.S., Blatt M.H., Wiesbader H., Filler W. Comparative clinical evaluation of estrogenic preparations by the menopausal and amenorrheal indices. J. Clin. Endocrinol. Metab. 1953;13:688\u2013703. doi: 10.1210/jcem-13-6-688.", "ArticleIdList": ["10.1210/jcem-13-6-688", "13061588"]}, {"Citation": "Kanadys W., Bara\u0144ska A., B\u0142aszczuk A., Polz-Dacewicz M., Drop B., Kanecki K., Malm M. Evaluation of clinical meaningfulness of red clover (Trifolium pratense L.) extract to relieve hot flushes and menopausal symptoms in peri-and post-menopausal women: A systematic review and meta-analysis of randomized controlled trials. Nutrients. 2021;13:1258. doi: 10.3390/nu13041258.", "ArticleIdList": ["10.3390/nu13041258", "PMC8069620", "33920485"]}, {"Citation": "Orleans R.J., Li L., Kim M.-J., Guo J., Sobhan M., Soule L., Joffe H.V. FDA Approval of Paroxetine for Menopausal Hot Flushes. N. Engl. J. Med. 2014;370:1777\u20131779. doi: 10.1056/NEJMp1402080.", "ArticleIdList": ["10.1056/NEJMp1402080", "24806158"]}, {"Citation": "Cheema D., Coomarasamy A., El-Toukhy T. Non-hormonal therapy of post-menopausal vasomotor symptoms: A structured evidence-based review. Arch. Gynecol. Obstet. 2007;276:463\u2013469. doi: 10.1007/s00404-007-0390-9.", "ArticleIdList": ["10.1007/s00404-007-0390-9", "17593379"]}, {"Citation": "Handley A.P., Williams M. The efficacy and tolerability of SSRI/SNRIs in the treatment of vasomotor symptoms in menopausal women: A systematic review. J. Am. Assoc. Nurse Pract. 2015;27:54\u201361. doi: 10.1002/2327-6924.12137.", "ArticleIdList": ["10.1002/2327-6924.12137", "24944075"]}, {"Citation": "Pizzorno J.E., Murray M.T. Textbook of Natural Medicine. 4th ed. Churchill Livingstone, An Imprint of Elsevier Inc.; St. Louis, MI, USA: 2013. pp. 660\u2013665."}, {"Citation": "European Medicines Agency (EMA) Committee on Herbal Medicinal Products (HMPC) EMA/HMPC/48744/2017 Assessment report on Cimicifuga racemosa (L.) Nutt., Rhizome. Volume 44. EMA; Amsterdam, The Netherlands: HMPC; London, UK: 2017. pp. 1\u201364."}, {"Citation": "European Medicines Agency (EMA) Committee on Herbal Medicinal Products (HMPC) EMA/HMPC/48745/2017 European Union Herbal Monograph on Cimicifuga racemosa (L.) Nutt., Rhizoma. Volume 44. EMA; Amsterdam, The Netherlands: HMPC; London, UK: 2017. pp. 1\u20138."}, {"Citation": "Kennelly E.J., Baggett S., Nuntanakorn P., Ososki A.L., Mori S.A., Duke J., Coleton M., Kronenberg F. Analysis of thirteen populations of black cohosh for formononetin. Phytomedicine. 2002;9:461\u2013467. doi: 10.1078/09447110260571733.", "ArticleIdList": ["10.1078/09447110260571733", "12222669"]}, {"Citation": "He K., Zheng B., Kim C.H., Rogers L., Zheng Q. Direct analysis and identification of triterpene glycosides by LC/MS in black cohosh, Cimicifuga racemosa, and in several commercially available black cohosh products. Planta Med. 2000;66:635\u2013640. doi: 10.1055/s-2000-8619.", "ArticleIdList": ["10.1055/s-2000-8619", "11105569"]}, {"Citation": "Reame N.E., Lukacs J.L., Padmanabhan V., Eyvazzadeh A.D., Smith Y.R., Zubieta J.K. Black cohosh has central opioid activity in postmenopausal women: Evidence from naloxone blockade and positron emission tomography neuroimaging. Menopause. 2008;15:832\u2013840. doi: 10.1097/gme.0b013e318169332a.", "ArticleIdList": ["10.1097/gme.0b013e318169332a", "PMC2915573", "18521048"]}, {"Citation": "Rhyu M.R., Lu J., Webster D.E., Fabricant D.S., Farnsworth N.R., Wang Z.J. Black cohosh (Actaea racemosa, Cimicifuga racemosa) behaves as a mixed competitive ligand and partial agonist at the human \u03bc opiate receptor. J. Agric. Food Chem. 2006;54:9852\u20139857. doi: 10.1021/jf062808u.", "ArticleIdList": ["10.1021/jf062808u", "PMC2547488", "17177511"]}, {"Citation": "Powell S.L., G\u00f6decke T., Nikolic D., Chen S.N., Ahn S., Dietz B., Farnsworth N.R., Van Breemen R.B., Lankin D.C., Pauli G.F., et al. In vitro serotonergic activity of black cohosh and identification of N\u03c9-methylserotonin as a potential active constituent. J. Agric. Food Chem. 2008;56:11718\u201311726. doi: 10.1021/jf803298z.", "ArticleIdList": ["10.1021/jf803298z", "PMC3684073", "19049296"]}, {"Citation": "Cicek S.S., Khom S., Taferner B., Hering S., Stuppner H. Bioactivity-guided isolation of GABAA receptor modulating constituents from the rhizomes of Actaea racemosa. J. Nat. Prod. 2010;73:2024\u20132028. doi: 10.1021/np100479w.", "ArticleIdList": ["10.1021/np100479w", "21082802"]}, {"Citation": "Cui G., Leng H., Wang K., Wang J., Zhu S., Jia J., Chen X., Zhang W., Qin L., Bai W. Effects of Remifemin treatment on bone integrity and remodeling in rats with ovariectomy-induced osteoporosis. PLoS ONE. 2013;8:e82815.", "ArticleIdList": ["PMC3857312", "24349369"]}, {"Citation": "Choi E.M. Deoxyactein stimulates osteoblast function and inhibits bone-resorbing mediators in MC3T3-E1 cells. J. Appl. Toxicol. 2013;33:190\u2013195. doi: 10.1002/jat.1733.", "ArticleIdList": ["10.1002/jat.1733", "21910134"]}, {"Citation": "Castelo-Branco C., Gambacciani M., Cano A., Minkin M.J., Racho\u0144 D., Ruan X., Beer A.M., Schnitker J., Henneicke-von Zepelin H.H., Pickartz S. Review & meta-analysis: Isopropanolic black cohosh extract iCR for menopausal symptoms\u2013an update on the evidence. Climacteric. 2021;24:109\u2013119.", "ArticleIdList": ["33021111"]}, {"Citation": "Uebelhack R., Blohmer J.U., Graubaum H.J., Busch R., Gruenwald J., Wernecke K.D. Black cohosh and St. John\u2019s wort for climacteric complaints: A randomized trial. Obstet. Gynecol. 2006;107:247\u2013255. doi: 10.1097/01.AOG.0000196504.49378.83.", "ArticleIdList": ["10.1097/01.AOG.0000196504.49378.83", "16449108"]}, {"Citation": "Bai W., Henneicke-von Zepelin H.H., Wang S., Zheng S., Liu J., Zhang Z., Geng L., Hu L., Chunfeng J., Liske E. Efficacy and tolerability of a medicinal product containing an isopropanolic black cohosh extract in Chinese women with menopausal symptoms: A randomized, double blind, parallel-controlled study versus tibolone. Maturitas. 2007;58:31\u201341. doi: 10.1016/j.maturitas.2007.04.009.", "ArticleIdList": ["10.1016/j.maturitas.2007.04.009", "17587516"]}, {"Citation": "Liske E., H\u00e4nggi W., Henneicke-von Zepelin H.H., Boblitz N., W\u00fcstenberg P., Rahlfs V.W. Physiological investigation of a unique extract of black cohosh (Cimicifugae racemosae rhizoma): A 6-month clinical study demonstrates no systemic estrogenic effect. J. Women\u2019s Health Gender-Based Med. 2002;11:163\u2013174. doi: 10.1089/152460902753645308.", "ArticleIdList": ["10.1089/152460902753645308", "11975864"]}, {"Citation": "Hostanska K., Nisslein T., Freudenstein J., Reichling J., Saller R. Cimicifuga racemosa extract inhibits proliferation of estrogen receptor-positive and negative human breast carcinoma cell lines by induction of apoptosis. Breast Cancer Res. Treat. 2004;84:151\u2013160. doi: 10.1023/B:BREA.0000018413.98636.80.", "ArticleIdList": ["10.1023/B:BREA.0000018413.98636.80", "14999145"]}, {"Citation": "Vitex agnus-castus L. Plants of the World Online, Kew Science.  [(accessed on 18 January 2021)].  Available online:  http://www.plantsoftheworldonline.org/taxon/urn:lsid:ipni.org:names:865568-1."}, {"Citation": "Schulz V., H\u00e4nsel R., Blumenthal M., Tyler V.E. Rational Phytotherapy: A Reference Guide for Physicians and Pharmacists. 5th ed. Springer; Berlin/Heidelberg, Germany: 2004. pp. 317\u2013332."}, {"Citation": "Certo G., Costa R., D\u2019Angelo V., Russo M., Albergamo A., Dugo G., German\u00f2 M.P. Anti-angiogenic activity and phytochemical screening of fruit fractions from Vitex agnus castus. Nat. Prod. Res. 2017;31:2850\u20132856. doi: 10.1080/14786419.2017.1303696.", "ArticleIdList": ["10.1080/14786419.2017.1303696", "28326847"]}, {"Citation": "Chen S.N., Friesen J.B., Webster D., Nikolic D., Van Breemen R.B., Wang Z.J., Fong H.H.S., Farnsworth N.R., Pauli G.F. Phytoconstituents from Vitex agnus-castus fruits. Fitoterapia. 2011;82:528\u2013533. doi: 10.1016/j.fitote.2010.12.003.", "ArticleIdList": ["10.1016/j.fitote.2010.12.003", "PMC3081944", "21163339"]}, {"Citation": "Masada S. Authentication of the botanical origin of Western herbal products using Cimicifuga and Vitex products as examples. J. Nat. Med. 2016;70:361\u2013375. doi: 10.1007/s11418-016-1006-0.", "ArticleIdList": ["10.1007/s11418-016-1006-0", "PMC4935754", "27188194"]}, {"Citation": "Oshima N., Masada S., Suzuki R., Yagi K., Matsufuji H., Suenaga E., Takahashi Y., Yahagi T., Watanabe M., Yahara S., et al. Identification of New Diterpenes as Putative Marker Compounds Distinguishing Agnus Castus Fruit (Chaste Tree) from Shrub Chaste Tree Fruit (Viticis fructus) Planta Med. 2016;82:147\u2013153. doi: 10.1055/s-0035-1558089.", "ArticleIdList": ["10.1055/s-0035-1558089", "26756820"]}, {"Citation": "European Directorate for the Quality of Medicines (EDQM) European Pharmacopoeia (Ph. Eur.) 10th ed. Council of Europe; Strasbourg, France: 2019."}, {"Citation": "European Medicines Agency (EMA) Committee on Herbal Medicinal Products (HMPC) EMA/HMPC/606742/2017 European Union Herbal Monograph on Vitex agnus-castus L., Fructus. Volume 44. EMA; Amsterdam, The Netherlands: HMPC; London, UK: 2018. pp. 1\u201310."}, {"Citation": "Hoberg E., Orjala J., Meier B., Sticher O. Diterpenoids from the fruits of Vitex agnus-castus. Phytochemistry. 1999;52:1555\u20131558. doi: 10.1016/S0031-9422(99)00181-8.", "ArticleIdList": ["10.1016/S0031-9422(99)00181-8"]}, {"Citation": "Wuttke W., Jarry H., Christoffel V., Spengler B., Seidlov\u00e1-Wuttke D. Chaste tree (Vitex agnus-castus)\u2014Pharmacology and clinical indications. Phytomedicine. 2003;10:348\u2013357. doi: 10.1078/094471103322004866.", "ArticleIdList": ["10.1078/094471103322004866", "12809367"]}, {"Citation": "Marjoribanks J., Brown J., O\u2019Brien P.M.S., Wyatt K. Selective serotonin reuptake inhibitors for premenstrual syndrome. Cochrane Database Syst. Rev. 2013;6:CD001396. doi: 10.1002/14651858.CD001396.pub3.", "ArticleIdList": ["10.1002/14651858.CD001396.pub3", "PMC7073417", "23744611"]}, {"Citation": "Turner S., Mills S. A double-blind clinical trial on a herbal remedy for premenstrual syndrome: A case study. Complement. Ther. Med. 1993;1:73\u201377. doi: 10.1016/0965-2299(93)90096-V.", "ArticleIdList": ["10.1016/0965-2299(93)90096-V"]}, {"Citation": "Lauritzen C., Reuter H.D., Repges R., B\u00f6hnert K.J., Schmidt U. Treatment of premenstrual tension syndrome with Vitex agnus castus controlled, double-blind study versus pyridoxine. Phytomedicine. 1997;4:183\u2013189. doi: 10.1016/S0944-7113(97)80066-9.", "ArticleIdList": ["10.1016/S0944-7113(97)80066-9", "23195474"]}, {"Citation": "Berger D., Schaffner W., Schrader E., Meier B., Brattstr\u00f6m A. Efficacy of Vitex agnus castus L. extract Ze 440 in patients with pre-menstrual syndrome (PMS) Arch. Gynecol. Obstet. 2000;264:150\u2013153. doi: 10.1007/s004040000123.", "ArticleIdList": ["10.1007/s004040000123", "11129515"]}, {"Citation": "Schellenberg R. Treatment for the premenstrual syndrome with agnus castus fruit extract: Prospective, randomised, placebo controlled study. Br. Med. J. 2001;322:134\u2013137. doi: 10.1136/bmj.322.7279.134.", "ArticleIdList": ["10.1136/bmj.322.7279.134", "PMC26589", "11159568"]}, {"Citation": "Halaska M., Beles P., Gorkow C., Sieder C. Treatment of cyclical mastalgia with a solution containing a Vitex agnus castus extract: Results of a placebo-controlled double-blind study. Breast. 1999;8:175\u2013181. doi: 10.1054/brst.1999.0039.", "ArticleIdList": ["10.1054/brst.1999.0039", "14731436"]}, {"Citation": "Ma L., Lin S., Chen R., Wang X. Treatment of moderate to severe premenstrual syndrome with Vitex agnus castus (BNO 1095) in Chinese women. Gynecol. Endocrinol. 2010;26:612\u2013616. doi: 10.3109/09513591003632126.", "ArticleIdList": ["10.3109/09513591003632126", "20334585"]}, {"Citation": "He Z., Chen R., Zhou Y., Geng L., Zhang Z., Chen S., Yao Y., Lu J., Lin S. Treatment for premenstrual syndrome with Vitex agnus castus: A prospective, randomized, multi-center placebo controlled study in China. Maturitas. 2009;63:99\u2013103. doi: 10.1016/j.maturitas.2009.01.006.", "ArticleIdList": ["10.1016/j.maturitas.2009.01.006", "19269753"]}, {"Citation": "Neghab N., Zamani M., Torabian S. Therapeutic Effect of Vitex Agnus Castus in Patients with Premenstrual Syndrome. Acta Med. Iran. 2012;50:101\u2013106.", "ArticleIdList": ["22359078"]}, {"Citation": "Csupor D., Lantos T., Hegyi P., Benk\u0151 R., Viola R., Gy\u00f6ngyi Z., Cs\u00e9csei P., T\u00f3th B., Vasas A., M\u00e1rta K., et al. Vitex agnus-castus in premenstrual syndrome: A meta-analysis of double-blind randomised controlled trials. Complement. Ther. Med. 2019;47:102190. doi: 10.1016/j.ctim.2019.08.024.", "ArticleIdList": ["10.1016/j.ctim.2019.08.024", "31780016"]}, {"Citation": "Atmaca M., Kumru S., Tezcan E. Fluoxetine versus Vitex agnus castus extract in the treatment of premenstrual dysphoric disorder. Hum. Psychopharmacol. 2003;18:191\u2013195. doi: 10.1002/hup.470.", "ArticleIdList": ["10.1002/hup.470", "12672170"]}, {"Citation": "Ciotta L., Pagano I., Stracquadanio M., Di Leo S., And\u00f2 A., Formusco C. Psychic aspects of the premenstrual dysphoric disorders. New therapeutic strategies: Our experience with Vitex agnus castus. Minerva Ginecol. 2011;63:237\u2013245.", "ArticleIdList": ["21654609"]}, {"Citation": "Schellenberg R., Zimmermann C., Drewe J., Hoexter G., Zahner C. Dose-dependent efficacy of the Vitex agnus castus extract Ze 440 in patients suffering from premenstrual syndrome. Phytomedicine. 2012;19:1325\u20131331. doi: 10.1016/j.phymed.2012.08.006.", "ArticleIdList": ["10.1016/j.phymed.2012.08.006", "23022391"]}, {"Citation": "Milewicz A., Gejdel E., Sworen H., Sienkiewicz K., Jedrzejak J., Teucher T., Schmitz H. Vitex agnus castus extract in the treatment of luteal phase defects due to latent hyperprolactinemia. Results of a randomized placebo-controlled double-blind study. Arzneimittelforschung. 1993;43:752\u2013756.", "ArticleIdList": ["8369008"]}, {"Citation": "Kilicdag E.B., Tarim E., Bagis T., Erkanli S., Aslan E., Ozsahin K., Kuscu E. Fructus agni casti and bromocriptine for treatment of hyperprolactinemia and mastalgia. Int. J. Gynecol. Obstet. 2004;85:292\u2013293. doi: 10.1016/j.ijgo.2004.01.001.", "ArticleIdList": ["10.1016/j.ijgo.2004.01.001", "15145274"]}, {"Citation": "Pakgohar M., Moradi M., Jamshidi A., Mehran A. Assessment of Vitex agnus-castus L. Extract Effect on Treatment of Premenstrual Syndrome. J. Med. Plants. 2009;8:98\u2013107."}, {"Citation": "Gerhard I., Patek A., Monga B., Blank A., Gorkow C. Mastodynon\u00ae bei weiblicher Sterilit\u00e4t. Complement. Med. Res. 1998;5:272\u2013278. doi: 10.1159/000021154.", "ArticleIdList": ["10.1159/000021154", "9973660"]}, {"Citation": "Van Die M.D., Burger H., Teede H., Bone K. Vitex agnus-castus extracts for female reproductive disorders: A systematic review of clinical trials. Planta Med. 2013;79:562\u2013575. doi: 10.1055/s-0032-1327831.", "ArticleIdList": ["10.1055/s-0032-1327831", "23136064"]}, {"Citation": "Cerqueira R.O., Frey B.N., Leclerc E., Brietzke E. Vitex agnus castus for premenstrual syndrome and premenstrual dysphoric disorder: A systematic review. Arch. Women\u2019s Ment. Health. 2017;20:713\u2013719. doi: 10.1007/s00737-017-0791-0.", "ArticleIdList": ["10.1007/s00737-017-0791-0", "29063202"]}, {"Citation": "Verkaik S., Kamperman A.M., van Westrhenen R., Schulte P.F.J. The treatment of premenstrual syndrome with preparations of Vitex agnus castus: A systematic review and meta-analysis. Am. J. Obstet. Gynecol. 2017;217:150\u2013166. doi: 10.1016/j.ajog.2017.02.028.", "ArticleIdList": ["10.1016/j.ajog.2017.02.028", "28237870"]}, {"Citation": "Jane\u0161 D., Glava\u010d N.K., editors. Modern Cosmetics, Ingredients of Natural Origin, a Scientific View. 1st ed. \u0160irimo dobro besedo d.o.o.; Velenje, Slovenia: 2018."}, {"Citation": "Oenothera biennis L. Plants of the World Online, Kew Science.  [(accessed on 15 January 2021)].  Available online:  http://www.plantsoftheworldonline.org/taxon/urn:lsid:ipni.org:names:172755-2."}, {"Citation": "Bayles B., Usatine R. Evening primprose oil. Am. Fam. Phys. 2009;80:1405\u20131408.", "ArticleIdList": ["20000302"]}, {"Citation": "European Medicines Agency (EMA) Committee on Herbal Medicinal Products (HMPC) EMA/HMPC/753041/2017 European Union Herbal Monograph on Oenothera biennis L. or Oenothera lamarckiana L., Oleum. Volume 44. EMA; Amsterdam, The Netherlands: HMPC; London, UK: 2018. pp. 1\u20136."}, {"Citation": "Cerin A., Collins A., And B.L., Eneroth P. Hormonal and biochemical profiles of premenstrual syndrome: Treatment with essential fatty acids. Acta Obstet. Gynecol. Scand. 1993;72:337\u2013343. doi: 10.3109/00016349309021108.", "ArticleIdList": ["10.3109/00016349309021108", "8392261"]}, {"Citation": "Horrobin D.F. The role of essential fatty acids and prostaglandins in the premenstrual syndrome. J. Reprod. Med. 1983;28:465\u2013468.", "ArticleIdList": ["6350579"]}, {"Citation": "Brush M.G., Watson S.J., Horrobin D.F., Manku M.S. Abnormal essential fatty acid levels in plasma of women with premenstrual syndrome. Am. J. Obstet. Gynecol. 1984;150:363\u2013366. doi: 10.1016/S0002-9378(84)80139-8.", "ArticleIdList": ["10.1016/S0002-9378(84)80139-8", "6091462"]}, {"Citation": "Puolakka J., Makarainen L., Viinikka L., Ylikorkala O. Biochemical and clinical effects of treating the premenstrual syndrome with prostaglandin synthesis precursors. J. Reprod. Med. Obstet. Gynecol. 1985;30:149\u2013153.", "ArticleIdList": ["3839018"]}, {"Citation": "Pye J.K., Mansel R.E., Hughes L.E. Clinical experience of drug treatments for mastalgia. Lancet. 1985;326:373\u2013377. doi: 10.1016/S0140-6736(85)92506-1.", "ArticleIdList": ["10.1016/S0140-6736(85)92506-1", "2862523"]}, {"Citation": "Massil H.Y., O\u2019Brien P.M.S. Approach to the management of premenstrual syndrome. Clin. Obstet. Gynecol. 1987;30:443\u2013452. doi: 10.1097/00003081-198706000-00024.", "ArticleIdList": ["10.1097/00003081-198706000-00024", "3608284"]}, {"Citation": "Pruthi S., Wahner-Roedler D.L., Torkelson C.J., Cha S.S., Thicke L.A., Hazelton J.H., Bauer B.A. Vitamin E and Evening Primrose Oil for Management of Cyclical Mastalgia: A Randomized Pilot Study. Altern. Med. Rev. 2010;15:59\u201367.", "ArticleIdList": ["20359269"]}, {"Citation": "Mcfayden I.J., Forrest A.P., Chetty U., Raab G. Cyclical breast pain\u2014Some observations and the difficulties in treatment. Br. J. Clin. Pract. 1992;46:161\u2013164.", "ArticleIdList": ["1286012"]}, {"Citation": "Blommers J., De Lange-de Klerk E.S.M., Kuik D.J., Bezemer P.D., Meijer S. Evening primrose oil and fish oil for severe chronic mastalgia: A randomized, double-blind, controlled trial. Am. J. Obstet. Gynecol. 2002;187:1389\u20131394. doi: 10.1067/mob.2002.127377a.", "ArticleIdList": ["10.1067/mob.2002.127377a", "12439536"]}, {"Citation": "Kashani L., Saedi N., Akhondzadeh S. Femicomfort in the treatment of premenstrual syndromes: A double-blind, randomized and placebo controlled trial. Iran. J. Psychiatry. 2010;5:47\u201350.", "ArticleIdList": ["PMC3430493", "22952490"]}, {"Citation": "Kazemi F., Masoumi S.Z., Shayan A., Oshvandi K. The Effect of Evening Primrose Oil Capsule on Hot Flashes and Night Sweats in Postmenopausal Women: A Single-Blind Randomized Controlled Trial. J. Menopausal Med. 2021;27:8. doi: 10.6118/jmm.20033.", "ArticleIdList": ["10.6118/jmm.20033", "PMC8102809", "33942584"]}, {"Citation": "Mehrpooya M., Rabiee S., Larki-Harchegani A., Fallahian A.-M., Moradi A., Ataei S., Javad M.T. A comparative study on the effect of \u201cblack cohosh\u201d and \u201cevening primrose oil\u201d on menopausal hot flashes. J. Educ. Health Promot. 2018;7:36.", "ArticleIdList": ["PMC5868221", "29619387"]}, {"Citation": "Cancelo Hidalgo M.J., Castelo-Branco C., Blumel J.E., Lanchares P\u00e9rez J.L., Alvarez De Los Heros J.I. Effect of a compound containing isoflavones, primrose oil and vitamin E in two different doses on climacteric symptoms. J. Obstet. Gynaecol. 2006;26:344\u2013347. doi: 10.1080/01443610600613417.", "ArticleIdList": ["10.1080/01443610600613417", "16753687"]}, {"Citation": "Khoo S.K., Munro C., Battistutta D. Evening primrose oil and treatment of premenstrual syndrome. Med. J. Aust. 1990;153:189\u2013192. doi: 10.5694/j.1326-5377.1990.tb136857.x.", "ArticleIdList": ["10.5694/j.1326-5377.1990.tb136857.x", "2201888"]}, {"Citation": "Collins A., Cerin A., Coleman G., Landgren B.M. Essential fatty acids in the treatment of premenstrual syndrome. Obstet. Gynecol. 1993;81:93\u201398.", "ArticleIdList": ["8416468"]}, {"Citation": "Goyal A., Mansel R.E. A randomized multicenter study of gamolenic acid (Efamast) with and without antioxidant vitamins and minerals in the management of mastalgia. Breast J. 2005;11:41\u201347. doi: 10.1111/j.1075-122X.2005.21492.x.", "ArticleIdList": ["10.1111/j.1075-122X.2005.21492.x", "15647077"]}, {"Citation": "Jaafarnejad F., Adibmoghaddam E., Emami S., Saki A. Compare the effect of flaxseed, evening primrose oil and Vitamin E on duration of periodic breast pain. J. Educ. Health Promot. 2017;6:85.", "ArticleIdList": ["PMC5651668", "29114553"]}, {"Citation": "Chenoy R., Hussain S., Tayob Y., O\u2019brien P.M.S., Moss M.Y., Morse P.F. Effect of oral gamolenic acid from evening primrose oil on menopausal flushing. BMJ. 1994;308:501\u2013503. doi: 10.1136/bmj.308.6927.501.", "ArticleIdList": ["10.1136/bmj.308.6927.501", "PMC2542782", "8136666"]}, {"Citation": "Budeiri D., Li Wan Po A., Dornan J.C. Is evening primrose oil of value in the treatment of premenstrual syndrome? Control. Clin. Trials. 1996;17:60\u201368. doi: 10.1016/0197-2456(95)00082-8.", "ArticleIdList": ["10.1016/0197-2456(95)00082-8", "8721802"]}, {"Citation": "Low Dog T. Menopause: A review of botanical dietary supplements. Am. J. Med. 2005;118:98\u2013108. doi: 10.1016/j.amjmed.2005.09.044.", "ArticleIdList": ["10.1016/j.amjmed.2005.09.044", "16414334"]}, {"Citation": "Dante G., Facchinetti F. Herbal treatments for alleviating premenstrual symptoms: A systematic review. J. Psychosom. Obstet. Gynecol. 2011;32:42\u201351. doi: 10.3109/0167482X.2010.538102.", "ArticleIdList": ["10.3109/0167482X.2010.538102", "21171936"]}, {"Citation": "Srivastava A., Mansel R.E., Arvind N., Prasad K., Dhar A., Chabra A. Evidence-based management of Mastalgia: A meta-analysis of randomised trials. Breast. 2007;16:503\u2013512. doi: 10.1016/j.breast.2007.03.003.", "ArticleIdList": ["10.1016/j.breast.2007.03.003", "17509880"]}, {"Citation": "Stevinson C., Ernst E. Complementary/alternative therapies for premenstrual syndrome: A systematic review of randomized controlled trials. Am. J. Obstet. Gynecol. 2001;185:227\u2013235. doi: 10.1067/mob.2001.113643.", "ArticleIdList": ["10.1067/mob.2001.113643", "11483933"]}, {"Citation": "Pakzad K., Boucher B.A., Kreiger N., Cotterchio M. The use of herbal and other non-vitamin, non mineral supplements among pre- and post-menopausal women in Ontario. Can. J. Public Health. 2007;98:383\u2013388. doi: 10.1007/BF03405424.", "ArticleIdList": ["10.1007/BF03405424", "PMC6975755", "17985680"]}, {"Citation": "Gentry-Maharaj A., Karpinskyj C., Glazer C., Burnell M., Ryan A., Fraser L., Lanceley A., Jacobs I., Hunter M.S., Menon U. Use and perceived efficacy of complementary and alternative medicines after discontinuation of hormone therapy: A nested United Kingdom Collaborative Trial of Ovarian Cancer Screening cohort study. Menopause. 2015;22:384\u2013390. doi: 10.1097/GME.0000000000000330.", "ArticleIdList": ["10.1097/GME.0000000000000330", "PMC4470524", "25290539"]}, {"Citation": "Gartoulla P., Davis S.R., Worsley R., Bell R.J. Use of complementary and alternative medicines for menopausal symptoms in Australian women aged 40\u201365 years. Med. J. Aust. 2015;203:146\u2013153. doi: 10.5694/mja14.01723.", "ArticleIdList": ["10.5694/mja14.01723", "26224187"]}, {"Citation": "Girman A., Lee R., Kligler B. An integrative medicine approach to premenstrual syndrome. Am. J. Obstet. Gynecol. 2003;188:S56\u2013S65. doi: 10.1067/mob.2003.403.", "ArticleIdList": ["10.1067/mob.2003.403", "12748452"]}, {"Citation": "European Medicines Agency (EMA) Committee on Herbal Medicinal Products (HMPC) EMA/HMPC/146220/2010 Assessment Report on Trigonella foenum-graecum L., Semen. Volume 44. EMA; Amsterdam, The Netherlands: HMPC; London, UK: 2010. pp. 1\u201342."}, {"Citation": "Nagulapalli Venkata K.C., Swaroop A., Bagchi D., Bishayee A. A small plant with big benefits: Fenugreek (Trigonella foenum-graecum Linn.) for disease prevention and health promotion. Mol. Nutr. Food Res. 2017;61:1600950. doi: 10.1002/mnfr.201600950.", "ArticleIdList": ["10.1002/mnfr.201600950", "28266134"]}, {"Citation": "Sreeja S., Anju V.S., Sreeja S. In vitro estrogenic activities of fenugreek Trigonella foenum graecum seeds. Indian J. Med. Res. 2010;131:814\u2013819.", "ArticleIdList": ["20571172"]}, {"Citation": "Shabbeer S., Sobolewski M., Anchoori R.K., Kachhap S., Davidson N., Carducci M.A., Khan S.R. Fenugreek a naturally occurring edible spice as an anticancer agent. Cancer Biol. Ther. 2009;8:272\u2013278. doi: 10.4161/cbt.8.3.7443.", "ArticleIdList": ["10.4161/cbt.8.3.7443", "PMC3095649", "19197146"]}, {"Citation": "Srinivasan S., Koduru S., Kumar R., Venguswamy G., Kyprianou N., Damodaran C. Diosgenin targets Akt-mediated prosurvival signaling in human breast cancer cells. Int. J. Cancer. 2009;125:961\u2013967. doi: 10.1002/ijc.24419.", "ArticleIdList": ["10.1002/ijc.24419", "19384950"]}, {"Citation": "Rao A., Steels E., Beccaria G., Inder W.J., Vitetta L. Influence of a Specialized Trigonella foenum-graecum Seed Extract (Libifem), on Testosterone, Estradiol and Sexual Function in Healthy Menstruating Women, a Randomised Placebo Controlled Study. Phyther. Res. 2015;29:1123\u20131130. doi: 10.1002/ptr.5355.", "ArticleIdList": ["10.1002/ptr.5355", "25914334"]}, {"Citation": "Younesy S., Amiraliakbari S., Esmaeili S., Alavimajd H., Nouraei S. Effects of fenugreek seed on the severity and systemic symptoms of dysmenorrhea. J. Reprod. Infertil. 2014;15:41\u201348.", "ArticleIdList": ["PMC3955423", "24695380"]}, {"Citation": "Hakimi S., Mohammad Alizadeh S., Delazar A., Abbasalizadeh F., Bamdad Mogaddam R., Siiahi M.R., Mostafa Garabagi P. Probable Effects of Fenugreek Seed on Hot Flash in Menopausal Women. J. Med. Plants. 2006;5:9\u201314."}, {"Citation": "Khanna A., John F., Das S., Thomas J., Rao J., Maliakel B., IM K. Efficacy of a novel extract of fenugreek seeds in alleviating vasomotor symptoms and depression in perimenopausal women: A randomized, double-blinded, placebo-controlled study. J. Food Biochem. 2020;44:e13507. doi: 10.1111/jfbc.13507.", "ArticleIdList": ["10.1111/jfbc.13507", "33025616"]}, {"Citation": "Thomas J.V., Rao J., John F., Begum S., Maliakel B., IM K., Khanna A. Phytoestrogenic effect of fenugreek seed extract helps in ameliorating the leg pain and vasomotor symptoms in postmenopausal women: A randomized, double-blinded, placebo-controlled study. Pharm. Nutr. 2020;14:100209. doi: 10.1016/j.phanu.2020.100209.", "ArticleIdList": ["10.1016/j.phanu.2020.100209"]}, {"Citation": "The Plant List: Search Results for \u201cHumulus\u201d.  [(accessed on 26 August 2021)].  Available online:  http://www.theplantlist.org/tpl1.1/search?q=Humulus."}, {"Citation": "Bocquet L., Sahpaz S., Hilbert J.L., Rambaud C., Rivi\u00e8re C. Humulus lupulus L., a very popular beer ingredient and medicinal plant: Overview of its phytochemistry, its bioactivity, and its biotechnology. Phytochem. Rev. 2018;17:1047\u20131090. doi: 10.1007/s11101-018-9584-y.", "ArticleIdList": ["10.1007/s11101-018-9584-y"]}, {"Citation": "Stevens J.F., Taylor A.W., Deinzer M.L. Quantitative analysis of xanthohumol and related prenylflavonoids in hops and beer by liquid chromatography-tandem mass spectrometry. J. Chromatogr. A. 1999;832:97\u2013107. doi: 10.1016/S0021-9673(98)01001-2.", "ArticleIdList": ["10.1016/S0021-9673(98)01001-2", "10070768"]}, {"Citation": "Stevens J.F., Ivancic M., Hsu V.L., Deinzer M.L. Prenylflavonoids from Humulus lupulus. Phytochemistry. 1997;44:1575\u20131585. doi: 10.1016/S0031-9422(96)00744-3.", "ArticleIdList": ["10.1016/S0031-9422(96)00744-3"]}, {"Citation": "Chadwiek L.R., Nikolic D., Burdette J.E., Overk C.R., Bolton J.L., Van Breemen R.B., Fr\u00f6hlich R., Fong H.H.S., Farnsworth N.R., Pauli G.F. Estrogens and congeners from spent hops (Humulus lupulus) J. Nat. Prod. 2004;67:2024\u20132032. doi: 10.1021/np049783i.", "ArticleIdList": ["10.1021/np049783i", "PMC7418824", "15620245"]}, {"Citation": "European Medicines Agency (EMA) Committee on Herbal Medicinal Products (HMPC) EMA/HMPC/682384/2013 Community Herbal Monograph on Humulus lupulus L., Flos. Volume 44. EMA; Amsterdam, The Netherlands: HMPC; London, UK: 2014. pp. 1\u20137."}, {"Citation": "Milligan S.R., Kalita J.C., Heyerick A., Rong H., De Cooman L., De Keukeleire D. Identification of a potent phytoestrogen in hops (Humulus lupulus L.) and beer. J. Clin. Endocrinol. Metab. 1999;84:2249\u20132252. doi: 10.1210/jcem.84.6.5887.", "ArticleIdList": ["10.1210/jcem.84.6.5887", "10372741"]}, {"Citation": "Koch W., Heim G. \u00d6strogene Hormone in Hopfen und Bier. Med. Wchnschr. 1953;95:845.", "ArticleIdList": ["13087082"]}, {"Citation": "Heyerick A., Vervarcke S., Depypere H., Bracke M., Keukeleire D. De A first prospective, randomized, double-blind, placebo-controlled study on the use of a standardized hop extract to alleviate menopausal discomforts. Maturitas. 2006;54:164\u2013175. doi: 10.1016/j.maturitas.2005.10.005.", "ArticleIdList": ["10.1016/j.maturitas.2005.10.005", "16321485"]}, {"Citation": "Erkkola R., Vervarcke S., Vansteelandt S., Rompotti P., De Keukeleire D., Heyerick A. A randomized, double-blind, placebo-controlled, cross-over pilot study on the use of a standardized hop extract to alleviate menopausal discomforts. Phytomedicine. 2010;17:389\u2013396. doi: 10.1016/j.phymed.2010.01.007.", "ArticleIdList": ["10.1016/j.phymed.2010.01.007", "20167461"]}, {"Citation": "Aghamiri V., Mirghafourvand M., Mohammad-Alizadeh-Charandabi S., Nazemiyeh H. The effect of Hop (Humulus lupulus L.) on early menopausal symptoms and hot flashes: A randomized placebo-controlled trial. Complement. Ther. Clin. Pract. 2016;23:130\u2013135. doi: 10.1016/j.ctcp.2015.05.001.", "ArticleIdList": ["10.1016/j.ctcp.2015.05.001", "25982391"]}, {"Citation": "Ferk F., Mi\u0161\u00edk M., Nersesyan A., Pichler C., J\u00e4ger W., Szekeres T., Marculescu R., Poulsen H.E., Henriksen T., Bono R., et al. Impact of xanthohumol (a prenylated flavonoid from hops) on DNA stability and other health-related biochemical parameters: Results of human intervention trials. Mol. Nutr. Food Res. 2016;60:773\u2013786. doi: 10.1002/mnfr.201500355.", "ArticleIdList": ["10.1002/mnfr.201500355", "26840505"]}, {"Citation": "Possemiers S., Bolca S., Grootaert C., Heyerick A., Decroos K., Dhooge W., De Keukeleire D., Rabot S., Verstraete W., Van De Wiele T. The prenylflavonoid isoxanthohumol from hops (Humulus lupulus L.) is activated into the potent phytoestrogen 8-prenylnaringenin in vitro and in the human intestine. J. Nutr. 2006;136:1862\u20131867. doi: 10.1093/jn/136.7.1862.", "ArticleIdList": ["10.1093/jn/136.7.1862", "16772450"]}, {"Citation": "Legette L., Karnpracha C., Reed R.L., Choi J., Bobe G., Christensen J.M., Rodriguez-Proteau R., Purnell J.Q., Stevens J.F. Human pharmacokinetics of xanthohumol, an antihyperglycemic flavonoid from hops. Mol. Nutr. Food Res. 2014;58:248\u2013255. doi: 10.1002/mnfr.201300333.", "ArticleIdList": ["10.1002/mnfr.201300333", "PMC4371792", "24038952"]}, {"Citation": "van Breemen R.B., Yuan Y., Banuvar S., Shulman L.P., Qiu X., Ramos Alvarenga R.F., Chen S.N., Dietz B.M., Bolton J.L., Pauli G.F., et al. Pharmacokinetics of prenylated hop phenols in women following oral administration of a standardized extract of hops. Mol. Nutr. Food Res. 2014;58:1962\u20131969. doi: 10.1002/mnfr.201400245.", "ArticleIdList": ["10.1002/mnfr.201400245", "PMC4265473", "25045111"]}, {"Citation": "Bolca S., Li J., Nikolic D., Roche N., Blondeel P., Possemiers S., De Keukeleire D., Bracke M., Heyerick A., Van Breemen R.B., et al. Disposition of hop prenylflavonoids in human breast tissue. Mol. Nutr. Food Res. 2010;54:S284\u2013S294. doi: 10.1002/mnfr.200900519.", "ArticleIdList": ["10.1002/mnfr.200900519", "PMC3856213", "20486208"]}, {"Citation": "Trifolium pratense L. Plants of the World Online, Kew Science.  [(accessed on 10 September 2021)].  Available online:  http://www.plantsoftheworldonline.org/taxon/urn:lsid:ipni.org:names:523575-1."}, {"Citation": "Trifolium Pratense (Red Clover): Go Botany.  [(accessed on 10 September 2021)].  Available online:  https://gobotany.nativeplanttrust.org/species/trifolium/pratense/"}, {"Citation": "Leme\u017eien\u0117 N., Padarauskas A., Butkut\u0117 B., Cesevi\u010dien\u0117 J., Taujenis L., Norkevi\u010dien\u0117 E., Mikali\u016bnien\u0117 J. The concentration of isoflavones in red clover (Trifolium pratense L.) at flowering stage. Zemdirbyste. 2015;102:443\u2013448. doi: 10.13080/z-a.2015.102.057.", "ArticleIdList": ["10.13080/z-a.2015.102.057"]}, {"Citation": "Nelsen J., Ulbricht C., Barrette E.P., Mac D.S., Tsouronis C., Rogers A., Basch S., Hashmi S., Bent S., Basch E. Red Clover (Trifolium pratense) Monograph. J. Herb. Pharmacother. 2002;2:49\u201372.", "ArticleIdList": ["15277090"]}, {"Citation": "Messina M., Mejia S.B., Cassidy A., Duncan A., Kurzer M., Nagato C., Ronis M., Rowland I., Sievenpiper J., Barnes S. Neither soyfoods nor isoflavones warrant classification as endocrine disruptors: A technical review of the observational and clinical data. Crit. Rev. Food Sci. Nutr. 2021:1\u201362. doi: 10.1080/10408398.2021.1895054.", "ArticleIdList": ["10.1080/10408398.2021.1895054", "33775173"]}, {"Citation": "European Medicines Agency (EMA) Committee on Herbal Medicinal Products (HMPC) EMA/HMPC/150848/2015, Corr. European Union Herbal Monograph on Valeriana officinalis L., Flos. Volume 31. EMA; Amsterdam, The Netherlands: HMPC; London, UK: 2016. pp. 1\u20139."}, {"Citation": "European Medicines Agency (EMA) Committee on Herbal Medicinal Products (HMPC) EMA/HMPC/150846/2015. Assessment report on Valeriana officinalis L., Radix and Valeriana officinalis L., Aetheroleum. Volume 31. EMA; Amsterdam, The Netherlands: HMPC; London, UK: 2015. pp. 1\u201371."}, {"Citation": "Usmanghani K., Saeed A., Muhammad Tanweer A. Indusyunic Medicine: Traditional Medicine of Herbal Animal and Mineral Origin in Pakistan. Department of Pharmacognosy, Faculty of Pharmacy, University of Karachi; Karachi, Pakistan: 1997."}, {"Citation": "Santos M.S., Ferreira F., Cunha A.P., Carvalho A.P., Macedo T. An aqueous extract of valerian influences the transport of GABA in synaptosomes. Planta Med. 1994;60:278\u2013279. doi: 10.1055/s-2006-959476.", "ArticleIdList": ["10.1055/s-2006-959476", "7997482"]}, {"Citation": "Ortiz J.G., Nieves-Natal J., Chavez P. Effects of Valeriana Officinalis extracts on [3H]flunitrazepam binding, synaptosomal [3H]GABA uptake, and hippocampal [3H]GABA release. Neurochem. Res. 1999;24:1373\u20131378. doi: 10.1023/A:1022576405534.", "ArticleIdList": ["10.1023/A:1022576405534", "10555777"]}, {"Citation": "Santos M.S., Ferreira F., Cunha A.P., Carvalho A.P., Ribeiro C.F., Macedo T. Synaptosomal GABA release as influenced by valerian root extract--involvement of the GABA carrier. Arch. Int. Pharmacodyn. Ther. 1994;327:220\u2013231.", "ArticleIdList": ["7979830"]}, {"Citation": "Cavades C., Ara\u00fajo I., Cotrim M.D., Amaral T., Cunha A.P., Macedo T., Ribeiro C.F. In vitro study on the interaction of Valeriana officinalis L. extracts and their amino acids on GABAA receptor in rat brain. Arzneimittelforschung. 1995;45:753\u2013755.", "ArticleIdList": ["8573216"]}, {"Citation": "Park J.Y., Lee Y., Lee H.J., Kwon Y.S., Chun W. In silico screening of GABA aminotransferase inhibitors from the constituents of Valeriana officinalis by molecular docking and molecular dynamics simulation study. J. Mol. Model. 2020;26:228. doi: 10.1007/s00894-020-04495-1.", "ArticleIdList": ["10.1007/s00894-020-04495-1", "32780180"]}, {"Citation": "Taavoni S., Ekbatani N., Kashaniyan M., Haghani H. Effect of valerian on sleep quality in postmenopausal women: A randomized placebo-controlled clinical trial. Menopause. 2011;18:951\u2013955. doi: 10.1097/gme.0b013e31820e9acf.", "ArticleIdList": ["10.1097/gme.0b013e31820e9acf", "21775910"]}, {"Citation": "Mirabi P., Mojab F. The effects of valerian root on hot flashes in menopausal women. Iran. J. Pharm. Res. 2013;12:217\u2013222.", "ArticleIdList": ["PMC3813196", "24250592"]}, {"Citation": "Jokar A., Kargosha A., Akarzadeh M., Asadi N., Setoudeh Z. Comparing the influence of relaxation training and consumption of valerian on insomnia of menopause women: A randomized clinical trial. Afr. J. Tradit. Complement. Altern. Med. 2016;13:40\u201344. doi: 10.4314/ajtcam.v13i1.6.", "ArticleIdList": ["10.4314/ajtcam.v13i1.6"]}, {"Citation": "Kazemian A., Parvin N., Raisi Dehkordi Z., Rafieian -Kopaei M. The Effect of Valerian on the Anxiety and Depression Symptoms of the Menopause in Women Referred to Shahrekord Medical Centers. J. Med. Plants. 2017;16:94\u2013101."}, {"Citation": "Jenabi E., Shobeiri F., Hazavehei S.M.M., Roshanaei G. The effect of Valerian on the severity and frequency of hot flashes: A triple-blind randomized clinical trial. Women Health. 2018;58:297\u2013304. doi: 10.1080/03630242.2017.1296058.", "ArticleIdList": ["10.1080/03630242.2017.1296058", "28278010"]}, {"Citation": "Glycine max subsp. soja (Siebold & Zucc.) H.Ohashi. Plants of the World Online, Kew Science.  [(accessed on 21 August 2021)].  Available online:  http://www.plantsoftheworldonline.org/taxon/urn:lsid:ipni.org:names:920989-1."}, {"Citation": "Wang K.J., Li X.H., Zhang J.J., Chen H., Zhang Z.L., Yu G.D. Natural introgression from cultivated soybean (Glycine max) into wild soybean (Glycine soja) with the implications for origin of populations of semi-wild type and for biosafety of wild species in China. Genet. Resour. Crop Evol. 2010;57:747\u2013761. doi: 10.1007/s10722-009-9513-4.", "ArticleIdList": ["10.1007/s10722-009-9513-4"]}, {"Citation": "Kuroda Y., Kaga A., Tomooka N., Yano H., Takada Y., Kato S., Vaughan D. QTL affecting fitness of hybrids between wild and cultivated soybeans in experimental fields. Ecol. Evol. 2013;3:2150\u20132168. doi: 10.1002/ece3.606.", "ArticleIdList": ["10.1002/ece3.606", "PMC3728954", "23919159"]}, {"Citation": "Xu Z., Ren T., Marowa P., You X., Lu X., Li Y., Zhang C. Establishment of a Cultivation Mode of Glycine soja, the Bridge of Phytoremediation and Industrial Utilization. Agronomy. 2020;10:595. doi: 10.3390/agronomy10040595.", "ArticleIdList": ["10.3390/agronomy10040595"]}, {"Citation": "Nawaz M.A., Lin X., Chan T.F., Ham J., Shin T.S., Ercisli S., Golokhvast K.S., Lam H.M., Chung G. Korean wild soybeans (Glycine soja sieb and zucc.): Geographic distribution and germplasm conservation. Agronomy. 2020;10:214. doi: 10.3390/agronomy10020214.", "ArticleIdList": ["10.3390/agronomy10020214"]}, {"Citation": "Murphy P.A., Barua K., Hauck C.C. Solvent extraction selection in the determination of isoflavones in soy foods. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 2002;777:129\u2013138. doi: 10.1016/S1570-0232(02)00342-2.", "ArticleIdList": ["10.1016/S1570-0232(02)00342-2", "12270206"]}, {"Citation": "European Medicines Agency (EMA) Committee on Herbal Medicinal Products (HMPC) EMA/HMPC/220598/2016. Assessment Report on Glycine max (L.) Merr., Lecithinum. Volume 31. EMA; Amsterdam, The Netherlands: HMPC; London, UK: 2017. pp. 2\u201327."}, {"Citation": "Izumi T., Piskula M.K., Osawa S., Obata A., Tobe K., Saito M., Kataoka S., Kubota Y., Kikuchi M. Soy isoflavone aglycones are absorbed faster and in higher amounts than their glucosides in humans. J. Nutr. 2000;130:1695\u20131699. doi: 10.1093/jn/130.7.1695.", "ArticleIdList": ["10.1093/jn/130.7.1695", "10867038"]}, {"Citation": "European Food Safety Authority (EFSA) Risk assessment for peri- and post-menopausal women taking food supplements containing isolated isoflavones. EFSA J. 2015;13:4246. doi: 10.2903/j.efsa.2015.4246.", "ArticleIdList": ["10.2903/j.efsa.2015.4246"]}, {"Citation": "Gramec Skledar D., Tvrd\u00fd V., Kenda M., Zega A., Pour M., Hork\u00fd P., Mlad\u011bnka P., Sollner Dolenc M., Peterlin Ma\u0161i\u010d L. Applicability of the OECD 455 in-vitro assay for determination of hERa agonistic activity of isoflavonoids. Toxicol. Appl. Pharmacol. 2020;386:114831. doi: 10.1016/j.taap.2019.114831.", "ArticleIdList": ["10.1016/j.taap.2019.114831", "31756431"]}, {"Citation": "Messina M. Soy and health update: Evaluation of the clinical and epidemiologic literature. Nutrients. 2016;8:754. doi: 10.3390/nu8120754.", "ArticleIdList": ["10.3390/nu8120754", "PMC5188409", "27886135"]}, {"Citation": "Taku K., Melby M.K., Kronenberg F., Kurzer M.S., Messina M. Extracted or synthesized soybean isoflavones reduce menopausal hot flash frequency and severity: Systematic review and meta-analysis of randomized controlled trials. Menopause. 2012;19:776\u2013790. doi: 10.1097/gme.0b013e3182410159.", "ArticleIdList": ["10.1097/gme.0b013e3182410159", "22433977"]}, {"Citation": "Faure E.D., Chantre P., Mares P. Effects of a standardized soy extract on hot flushes: A multicenter, double-blind, randomized, placebo-controlled study. Menopause. 2002;9:329\u2013334. doi: 10.1097/00042192-200209000-00005.", "ArticleIdList": ["10.1097/00042192-200209000-00005", "12218721"]}, {"Citation": "Stanosz S., Puk E., Grobelny W., Stanosz M., Kazikowska A. Evaluation of the efficacy and tolerance of Soyfem in women in the early menopausal period. Prz. Menopauzalny. 2006;5:182\u2013190."}, {"Citation": "Messina M., Venter C. Recent Surveys on Food Allergy Prevalence. Nutr. Today. 2020;55:22\u201329. doi: 10.1097/NT.0000000000000389.", "ArticleIdList": ["10.1097/NT.0000000000000389"]}, {"Citation": "Katz Y., Gutierrez-Castrellon P., Gonz\u00e1lez M.G., Rivas R., Lee B.W., Alarcon P. A comprehensive review of sensitization and allergy to soy-based products. Clin. Rev. Allergy Immunol. 2014;46:272\u2013281. doi: 10.1007/s12016-013-8404-9.", "ArticleIdList": ["10.1007/s12016-013-8404-9", "24425446"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "10", "Day": "31"}, {"Year": "2021", "Month": "11", "Day": "29"}, {"Year": "2021", "Month": "12", "Day": "2"}, {"Year": "2021", "Month": "12", "Day": "24", "Hour": "1", "Minute": "11"}, {"Year": "2021", "Month": "12", "Day": "25", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "2", "Day": "15", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "12", "Day": "8"}], "PublicationStatus": "epublish", "ArticleIdList": ["34946512", "PMC8708702", "10.3390/molecules26247421", "molecules26247421"]}}], "PubmedBookArticle": []}